Kolhapur researchers receives 20 years patent for their Breast Cancer drug

▴ Kolhapur researchers receives 20 years patent for their Breast Cancer drug
A new breakthrough for Breast Cancer patients

Researchers at the Shivaji University Kolhapur (SUK) have received a patent for the chemical complex (molecule) drug synthesised in a university lab which showed anti-breast cancer properties.

Assistant Professor Prakash Bansode under the guidance of Gajanan Rashinkar synthesised the drug molecule for over 3 months.

The molecule contains a Ferrocine compound which normally kills normal cells also during chemotherapy apart from destroying normal cells. To overcome the problem researchers coupled the compound with Carbene structure to which they added metallic components such as Gold, Silver and Platinum. 

According to the researchers, the drug was screened at Advanced Cancer Research Centre of Tata Memorial. The patent application which was filed in March 2018 was reviewed and the drug was granted a 20 years product patent.

Tags : #Kolhapur #ShivajiUniversityKolhapur #ShivajiUniversity #Ferrocine #BreastCancerTreatment #TataCancerMemorial #TataAdvanceResearchCentre #PrakashBansode #GajananRashinkar

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024